Related references
Note: Only part of the references are listed.Clinical and Genetic Characteristics in Young, Glucocorticoid-Naive Boys With Duchenne Muscular Dystrophy
Marianela Schiava et al.
NEUROLOGY (2022)
Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy
Francesco Muntoni et al.
PLOS ONE (2019)
Is There a Delay in Diagnosis of Duchenne Muscular Dystrophy Among Preterm-Born Males?
Aida Soim et al.
JOURNAL OF CHILD NEUROLOGY (2018)
Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
Craig M. McDonald et al.
LANCET (2018)
Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan
David J. Birnkrant et al.
LANCET NEUROLOGY (2018)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management (vol 17, pg 251, 2018)
J. F. Zimmermann et al.
LANCET NEUROLOGY (2018)
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management
David J. Birnkrant et al.
LANCET NEUROLOGY (2018)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
David J. Birnkrant et al.
LANCET NEUROLOGY (2018)
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Craig M. McDonald et al.
LANCET (2017)
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy
Michela Guglieri et al.
CONTEMPORARY CLINICAL TRIALS (2017)
Results of North Star Ambulatory Assessments in the Phase 3 Ataluren Confirmatory Trial in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD)
J. Kirschner et al.
NEUROPEDIATRICS (2016)
Improving recognition of Duchenne muscular dystrophy: a retrospective case note review
Henriette J. A. van Ruiten et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2014)
Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
Marika Pane et al.
PLOS ONE (2014)
THE 6-MINUTE WALK TEST AND OTHER CLINICAL ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: RELIABILITY, CONCURRENT VALIDITY, AND MINIMAL CLINICALLY IMPORTANT DIFFERENCES FROM A MULTICENTER STUDY
Craig M. McDonald et al.
MUSCLE & NERVE (2013)
Six-Minute Walk Test: Reference Values and Prediction Equation in Healthy Boys Aged 5 to 12 Years
Nathalie Goemans et al.
PLOS ONE (2013)
Evidence-Based Path to Newborn Screening for Duchenne Muscular Dystrophy
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2012)
International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy
Eugenio Mercuri et al.
NEUROMUSCULAR DISORDERS (2012)
Deletions in the dystrophin gene predict loss of ambulation before 10 years of age in boys with Duchenne muscular dystrophy
Z. E. Davidson et al.
NEUROMUSCULAR DISORDERS (2012)
Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy
Elaine Scott et al.
PHYSIOTHERAPY RESEARCH INTERNATIONAL (2012)
Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up
Francesca Magri et al.
JOURNAL OF NEUROLOGY (2011)
THE 6-MINUTE WALK TEST AS A NEW OUTCOME MEASURE IN DUCHENNE MUSCULAR DYSTROPHY
Craig M. McDonald et al.
MUSCLE & NERVE (2010)
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy
Elena Mazzone et al.
NEUROMUSCULAR DISORDERS (2010)
Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
Emma Ciafaloni et al.
JOURNAL OF PEDIATRICS (2009)
Reliability of the North Star Ambulatory Assessment in a multicentric setting
E. S. Mazzone et al.
NEUROMUSCULAR DISORDERS (2009)
Share Paper
